Faculty profile

Kimberly Morishita

ResearcherPediatricsUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Kimberly Morishita

Researcher

Pediatrics

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
1 publication in the last five years, latest in 2022.
Principal investigator on 1 research grant (1 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

578

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Biomarkers Histopathology Kidney Pediatrics Prognostic Tools Urine Vasculitis

Latest papers

Development and validation of the Kids Disability Screen for children with juvenile idiopathic arthritis: results from the CAPRI Registry.
Rheumatology (Oxford, England) · 2022
Higher concentrations of vitamin D in Canadian children with juvenile idiopathic arthritis compared to healthy controls are associated with more frequent use of vitamin D supplements and season of birth.
Nutrition research (New York, N.Y.) · 2021
Clinical and psychosocial stress factors are associated with decline in physical activity over time in children with juvenile idiopathic arthritis
Pediatric Rheumatology · 2021

All 19 publications

Latest funding

Pediatric-Specific Prognostication in ANCA-GN: Validation of Adult Risk Scores and Discovery of Novel Biomarkers
CIHR · 2026 · Principal investigator
$405,450
Evaluating the utility of adult-defined prognostic biomarkers: Are they appropriate in childhood onset primary chronic vasculitis?
CIHR · 2021 · Co-investigator
$290,700

All 2 grants and awards

19 publications.

Development and validation of the Kids Disability Screen for children with juvenile idiopathic arthritis: results from the CAPRI Registry.

Houghton K, McPherson M, Surjanovic N, Loughin T, Berard R, Proulx-Gauthier JP, Chédeville G, Rumsey D, Schmeling H, Luca N, Johnson N, Gerschman T, Miettunen P, Tam H, Lim L, Morishita K, Scuccimarri R, Roth J, Duffy C, Tucker L, Feldman BM, Guzman J, CAPRI Registry Investigators

Rheumatology (Oxford, England)2022

DOI: 10.1093/rheumatology/keac146 PMID: 35438140

Higher concentrations of vitamin D in Canadian children with juvenile idiopathic arthritis compared to healthy controls are associated with more frequent use of vitamin D supplements and season of birth.

Finch SL, Rosenberg AM, Kusalik AJ, Maleki F, Rezaei E, Baxter-Jones A, Benseler S, Boire G, Cabral D, Campillo S, Chédeville G, Chetaille AL, Dancey P, Duffy C, Duffy KW, Guzman J, Houghton K, Huber AM, Jurencak R, Lang B, Laxer RM, Morishita K, Oen KG, Petty RE, Ramsey SE, Roth J, Schneider R, Scuccimarri R, Stringer E, Tse SML, Tucker LB, Turvey SE, Szafron M, Whiting S, Yeung RS, Vatanparast H, BBOP Study Group

Nutrition research (New York, N.Y.)2021

DOI: 10.1016/j.nutres.2021.05.007 PMID: 34311227

Clinical and psychosocial stress factors are associated with decline in physical activity over time in children with juvenile idiopathic arthritis

Heale LD, Houghton KM, Rezaei E, Baxter-Jones ADG, Tupper SM, Muhajarine N, Benseler SM, Boire G, Cabral DA, Campillo S

Pediatric Rheumatology202110 citationsOpen Access

DOI: 10.1186/s12969-021-00584-4 PMID: W3127374204

Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritis.

Rezaei E, Hogan D, Trost B, Kusalik AJ, Boire G, Cabral DA, Campillo S, Chédeville G, Chetaille AL, Dancey P, Duffy C, Watanabe Duffy K, Gordon J, Guzman J, Houghton K, Huber AM, Jurencak R, Lang B, Morishita K, Oen KG, Petty RE, Ramsey SE, Scuccimarri R, Spiegel L, Stringer E, Taylor-Gjevre RM, Tse SML, Tucker LB, Turvey SE, Tupper S, Yeung RSM, Benseler S, Ellsworth J, Guillet C, Karananayake C, Muhajarine N, Roth J, Schneider R, Rosenberg AM

Rheumatology (Oxford, England)2020

DOI: 10.1093/rheumatology/kez615 PMID: 31919503

Associations of clinical and inflammatory biomarker clusters with juvenile idiopathic arthritis categories.

Rezaei E, Hogan D, Trost B, Kusalik AJ, Boire G, Cabral DA, Campillo S, Chédeville G, Chetaille AL, Dancey P, Duffy C, Duffy KW, Eng SWM, Gordon J, Guzman J, Houghton K, Huber AM, Jurencak R, Lang B, Laxer RM, Morishita K, Oen KG, Petty RE, Ramsey SE, Scherer SW, Scuccimarri R, Spiegel L, Stringer E, Taylor-Gjevre RM, Tse SML, Tucker LB, Turvey SE, Tupper S, Wintle RF, Yeung RSM, Rosenberg AM, BBOP Study Group

Rheumatology (Oxford, England)2020

DOI: 10.1093/rheumatology/kez382 PMID: 32321162

Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience

Chhabra A, Robinson C, Houghton K, Cabral DA, Morishita K, Tucker LB, Petty RE, Larché M, Batthish M, Guzman J

Rheumatology202070 citationsOpen Access

DOI: 10.1093/rheumatology/keaa118 PMID: W3025695163

Real‐World Effectiveness of Common Treatment Strategies for Juvenile Idiopathic Arthritis: Results From a Canadian Cohort

Chhabra A, Oen K, Huber AM, Shiff NJ, Boire G, Benseler SM, Berard RA, Scuccimarri R, Feldman BM, Lim LSH

Arthritis Care and Research202017 citations

DOI: 10.1002/acr.23922

Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort.

Guzman J, Henrey A, Loughin T, Berard RA, Shiff NJ, Jurencak R, Huber AM, Oen K, Gerhold K, Feldman BM

Journal of Rheumatology201935 citations

DOI: 10.3899/jrheum.180456

Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review.

Mansour M, Liy Wong C, Zulian F, Li S, Morishita K, Yeh EA, Stewart K, Laxer RM, Pope E

Pediatric dermatology2018

DOI: 10.1111/pde.13605 PMID: 30187959

Trajectories of pain severity in juvenile idiopathic arthritis

Shiff NJ, Tupper S, Oen K, Guzman J, Lim H, Lee CH, Bryce R, Huber AM, Boire G, Dancey P

Pain201842 citations

DOI: 10.1097/j.pain.0000000000001064

Something wrong or missing on this profile? Suggest a correction

Kimberly Morishita

Research

Latest papers

Latest funding

Development and validation of the Kids Disability Screen for children with juvenile idiopathic arthritis: results from the CAPRI Registry.

Higher concentrations of vitamin D in Canadian children with juvenile idiopathic arthritis compared to healthy controls are associated with more frequent use of vitamin D supplements and season of birth.

Clinical and psychosocial stress factors are associated with decline in physical activity over time in children with juvenile idiopathic arthritis

Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritis.

Associations of clinical and inflammatory biomarker clusters with juvenile idiopathic arthritis categories.

Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience

Real‐World Effectiveness of Common Treatment Strategies for Juvenile Idiopathic Arthritis: Results From a Canadian Cohort

Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort.

Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review.

Trajectories of pain severity in juvenile idiopathic arthritis

Pediatric-Specific Prognostication in ANCA-GN: Validation of Adult Risk Scores and Discovery of Novel Biomarkers

Evaluating the utility of adult-defined prognostic biomarkers: Are they appropriate in childhood onset primary chronic vasculitis?

Frequent collaborators

Jaime Guzman

Johannes Roth

Margaret Larche

Susanne Benseler

Heinrike Schmeling

David Cabral

Stuart Turvey

Nazeem Muhajarine

Rae Yeung

John Gordon

Brian Feldman

Michael Szafron

Lori Tucker

Susanne Benseler

Michelle Batthish

Julie Barsalou

Elie Haddad

Liane Heale

Kelly Brown

Jinhui Ma